Leishmaniasis during the increased Syrian refugee traffic
Journal: Global Journal of Infectious Diseases and Clinical Research (Vol.4, No. 2)Publication Date: 2018-08-28
Authors : Nurittin Ardic Alper Fatih Ardic; Zeynep Gunel;
Page : 013-016
Keywords : Leishmaniasis; Population movemen;
Abstract
Especially in recent years, important population mobility occurs worldwide, including refugee crisis affecting especially Middle East and Europe. Consequently, like other infectious diseases have significance for public health, leishmaniasis is spreading globally. 350 million people in 88 countries, mostly in developing areas, are at risk of leishmaniasis. The diseases may be seen in three clinical forms as cutaneous, mucocutaneous, or visceral caused by about 20 different species of Leishmania parasite. The parasitological diagnosis is made by microscopic examination, cultivation, PCR and serological methods. There is currently no available vaccine for this infection. Pentavalent antimonials are the first line therapeutic choice, whereas amphotericin B, pentamidine, miltefosine, and paromomycin are alternative drugs. Other side, increasing resistance and toxicity of the current therapeutics are significant problems. The combination therapy, immunotherapy, anti-leishmanial synthetic and natural products, and local hyperthermic applications are promising for future treatment of leishmaniasis. The preventive efforts have been applying based on individuals and community.In CHB patients, habits of drinking alcohol and cigarette smoking, elevated serum levels of TBil and serum AST/ALT ratio, increased duration of hepatitis B, a family of hepatitis B, male gender and older age can increase the risk of LC development.
Other Latest Articles
- Emergent of Colistin Resistant Enterobacteriaceae carrying the mcr-1 gene among clinical isolates from patients in an Argentine hospital: Clinical and microbiological aspects
- Comparative Study of Methods of Differential Diagnosis of Essential Resistant and Pseudoresistant Arterial Hypertension in the Practice of Doctor of General Practice
- The Effectiveness of Patient-Oriented Correction of Adherence to Treatment in Patients with Arterial Hypertension and Comorbid Chronic Obstructive Pulmonary Disease
- Clinical and Laboratory Peculiarities of Chronic Active M. Epstein – I. Barr Virus Infection Course in Patients with Allergic Diseases
- Efficiency of L-arginine and L-carnitine in the Complex Treatment of Patients With Acute Myocardial Infarction and Comorbid Metabolic Syndrome
Last modified: 2019-03-19 22:39:34